Amgen said it will lay off 12 to 15 percent of its worldwide workforce and close four sites, even as it reported stellar second-quarter results that trounced Wall Street expectations.
Dendreon Corporation announced that its board of directors has appointed W. Thomas Amick as...
AstraZeneca today announced that it has entered an agreement to transfer to the company the...
Baxter International has entered into a definitive agreement to sell its two commercially...
Management failures by the Obama administration set the stage for the computer woes that paralyzed the president's new health care program last fall, nonpartisan investigators said in testimony released Wednesday.
Facing ballooning costs for a $1,000 pill to treat hepatitis C, Illinois' Medicaid program is putting tight restrictions in place, including requiring patients to meet 25 criteria and get prior approval before the government program will pay for the new drug.
There has always been much hand-wringing and shouting regarding the costs of new medications. Most of this comes from people outside the industry – politicians, public health advocates, and a smattering of those that just like to hear themselves talk.
Introducing the EZ-Fit™ Filtration Unit, a ready-to-use, disposable filtration device for bioburden testing.
McKesson Corporation today announced a three-year extension of its existing distribution agreement with CVS Caremark through June, 2019.
AstraZeneca today announced that it has entered into a clinical study collaboration with Kyowa Hakko Kirin for a Phase I/Ib immuno-oncology study that will evaluate the safety and efficacy of two separate combinations of three investigational compounds in multiple solid tumours.
The Multiple Myeloma Research Foundation encourages research centers to give their data free to anyone that wants it, which can lead to faster trials and drug development.
Packaging Coordinators has reached a definitive agreement to acquire Penn Pharmaceutical Services Limited. Penn Pharma is headquartered in Tredegar, Wales in the United Kingdom and operates regional offices in New Hope, Pennsylvania and Tokyo, Japan.
A leading doctor who risked his own life to treat dozens of Ebola patients died Tuesday from the disease, officials said, as a major regional airline announced it was suspending flights to the cities hardest hit by an outbreak that has killed more than 670 people.
A California man who disappeared after refusing treatment for tuberculosis, which can be contagious and spreads by coughing or sneezing, was found and arrested on charges of refusing to comply with health officials.
Regeneron Pharmaceuticals announced that the FDA has approved EYLEA Injection for the treatment of Diabetic Macular Edema (DME). The recommended dosage of EYLEA in patients with DME is 2 milligrams every two months after five initial monthly injections.
Shares of Impax Labs sank Tuesday after an FDA inspection uncovered potential problems at a facility where the company will make its experimental Parkinson's disease drug Rytary.
Stop sunbathing and using indoor tanning beds, the acting U.S. surgeon general warned in a report released Tuesday that cites an alarming 200 percent jump in deadly melanoma cases since 1973.
ISPE has hired John Bournas as President and CEO, succeeding Nancy Berg who announced plans to leave the Society last fall. Mr. Bournas takes the helm at ISPE with extensive competencies in the healthcare association industry as well as significant international experience.
Fitch Ratings expects that revenues from biologic therapies as a percentage of total pharmaceutical sales will continue to increase over the intermediate term as companies increase their prominence in their drug portfolios, according to a report published today.